Učitavanje...
The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway
Controlling cholesterol levels is a major challenge in human health, since hypercholesterolemia can lead to serious cardiovascular disease. Drugs that target carbohydrate metabolism can also modify lipid metabolism and hence cholesterol plasma levels. In this sense, dichloroacetate (DCA), a pyruvate...
Spremljeno u:
Izdano u: | Sci Rep |
---|---|
Glavni autori: | , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Nature Publishing Group UK
2017
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5587676/ https://ncbi.nlm.nih.gov/pubmed/28878225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-10339-5 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|